UNA COMPOSICION FARMACEUTICA QUE COMPRENDE ACIDO 1-(3-CIANO-1-ISOPROPIL-INDOL-5-IL)PIRAZOL-4-CARBOXILICO
La presente invencion se refiere a una composicion farmaceutica que comprende acido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxilo o una sal farmaceuticamente aceptable del mismo, para ser administrada por via oral a un sujeto en una dosificacion de 50 a 200 mg/dia, donde el sujeto tiene una...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Spanish |
Published |
16.02.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | La presente invencion se refiere a una composicion farmaceutica que comprende acido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxilo o una sal farmaceuticamente aceptable del mismo, para ser administrada por via oral a un sujeto en una dosificacion de 50 a 200 mg/dia, donde el sujeto tiene una tasa de filtracion glomerular estimada (eGFR) de menos de 90 mL/min/1,73 m2. Dicha composicion es util para tratar o prevenir una enfermedad relacionada con la hiperuricemia, tal como es gota, exacerbacion de gota recurrente, artritis gotosa, hipertension, enfermedad cardiovascular, cardiopatia coronaria, entre otras.
The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or preventing a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the blood uric acid concentration in a patient with a hyperuricemia-related disease. |
---|---|
AbstractList | La presente invencion se refiere a una composicion farmaceutica que comprende acido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxilo o una sal farmaceuticamente aceptable del mismo, para ser administrada por via oral a un sujeto en una dosificacion de 50 a 200 mg/dia, donde el sujeto tiene una tasa de filtracion glomerular estimada (eGFR) de menos de 90 mL/min/1,73 m2. Dicha composicion es util para tratar o prevenir una enfermedad relacionada con la hiperuricemia, tal como es gota, exacerbacion de gota recurrente, artritis gotosa, hipertension, enfermedad cardiovascular, cardiopatia coronaria, entre otras.
The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or preventing a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the blood uric acid concentration in a patient with a hyperuricemia-related disease. |
Author | SHIN, Seong Hye KIM, Junyu MUNE, June Sik MIN, Ji Young KIM, Min Hee SEO, Jung Youn LEE, Jieun GWAK, Heemin |
Author_xml | – fullname: GWAK, Heemin – fullname: LEE, Jieun – fullname: SHIN, Seong Hye – fullname: KIM, Junyu – fullname: MIN, Ji Young – fullname: MUNE, June Sik – fullname: KIM, Min Hee – fullname: SEO, Jung Youn |
BookMark | eNqNiksKwkAQBbPQhb87jDtdNJiPB2g7E2xIpsdJAuImBBlxIUkg3h-DeADhQVHUWwazru_8InjWBhVJYaVkYjEqQ1cg6bpiQnWp9Tc6bVKtkDgVFcIuBmI0AiFwKdaJ5RzYpJLDETjfW3Z4myQBQneSK-dMsg7mj_Y1-s2Pq2Cb6YrO4Ie-8ePQ3n3n343V0SFKpkUYxv98Phu1NpU |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | PE20240242A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_PE20240242A13 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 06 06:12:35 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_PE20240242A13 |
Notes | Application Number: PE2023003221 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240216&DB=EPODOC&CC=PE&NR=20240242A1 |
ParticipantIDs | epo_espacenet_PE20240242A1 |
PublicationCentury | 2000 |
PublicationDate | 20240216 |
PublicationDateYYYYMMDD | 2024-02-16 |
PublicationDate_xml | – month: 02 year: 2024 text: 20240216 day: 16 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | LG CHEM, LTD |
RelatedCompanies_xml | – name: LG CHEM, LTD |
Score | 3.3662052 |
Snippet | La presente invencion se refiere a una composicion farmaceutica que comprende acido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxilo o una sal... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | UNA COMPOSICION FARMACEUTICA QUE COMPRENDE ACIDO 1-(3-CIANO-1-ISOPROPIL-INDOL-5-IL)PIRAZOL-4-CARBOXILICO |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240216&DB=EPODOC&locale=&CC=PE&NR=20240242A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFA5jinrTqej8QQUpegi6Nm31MCRLUxZpm9itMryMtutQD9twFf99X0vnvOgtyYOQPPKS70vee0HoMgeIYN9bCXYMMsEkmUxx4uSwlo3MzBwzBTJXxg4Hod2PyePIGjXQ-yoWpsoT-lUlRwSLysDei2q_XqwvsdzKt3J5k75B0_zBG3ZdvWbH5VNBx9bdXpcr6UqmM9ZVXA-jWkYMCkxpo4TRZZ59_twro1IWv48UbxdtKuhtVuyhRr5soW22-nmthbaC-sEbirXtLffRaxxSjclAyYFgsANqHo0Cyng8FIxqTzGvhBEPXa5RJlypdfCViZmgoQQGJwZSRVIJH4vQlT62sPCvlYjoC1QIZjTqyZHwBZMH6MLjQ9bHMOTxj37Giq9nZx6i5mw-y4-QZk0NkgH-SomdkNupnebAhcy7vAQxTicxj1H7737a_wlP0E5ZKZ2XO_YpahYfn_kZnM1Fel4p9Rt4g4lS |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFG-WaZw3P6PzCxND9NDooIAeFtOVklWBIgOzeFmAsaiHbXEY_30fhDkvemv7S5r2pa_v_fr6WoQucnARzDsjwZZGxpgk4wlOrBzWspbpmaWnQObK3GHPN_sxeRgawwZ6X-bCVO-EflWPI4JGZaDvRbVfz1eHWHZ1t3Jxnb5B0-zeibq2WrPjMlTQMVW71-WBtCVTGesGXPXDGiMaBaa0ZgElrKjSc6_MSpn_NinOFloPoLdpsY0a-WIHtdjy57UdtOHVAW8o1rq32EWvsU8VJr1ADgSDHVBxaOhRxuNIMKo8xbwCQ-7bXKFM2FLp4EsdM0F9CQxODGQQykC4WPi2dLGBhXsViJC-QIVgRsOeHApXMLmHzh0esT6GIY9-5DMK-Gp2-j5qTmfT_AApxkQjGfhfKTETcjMx0xy4kH6bl06M1Un0Q9T-u5_2f-AZavUjzx25wn88QpslUF5k7pjHqFl8fOYnYKeL9LQS8DcJlIw8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=UNA+COMPOSICION+FARMACEUTICA+QUE+COMPRENDE+ACIDO+1-%283-CIANO-1-ISOPROPIL-INDOL-5-IL%29PIRAZOL-4-CARBOXILICO&rft.inventor=GWAK%2C+Heemin&rft.inventor=LEE%2C+Jieun&rft.inventor=SHIN%2C+Seong+Hye&rft.inventor=KIM%2C+Junyu&rft.inventor=MIN%2C+Ji+Young&rft.inventor=MUNE%2C+June+Sik&rft.inventor=KIM%2C+Min+Hee&rft.inventor=SEO%2C+Jung+Youn&rft.date=2024-02-16&rft.externalDBID=A1&rft.externalDocID=PE20240242A1 |